Nutra Pharma Corp.
NPHC · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,074 | $6,722 | $8,084 | $14,662 |
| - Cash | -$20 | $10 | $7 | $91 |
| + Debt | $8,035 | $8,514 | $7,434 | $8,195 |
| Enterprise Value | $14,129 | $15,225 | $15,511 | $22,766 |
| Revenue | $109 | $90 | $22 | $26 |
| % Growth | 20.8% | 307.1% | -14.6% | – |
| Gross Profit | $68 | $30 | $8 | -$39 |
| % Margin | 62.4% | 32.7% | 35.1% | -150.1% |
| EBITDA | $798 | -$440 | $5,231 | $2,325 |
| % Margin | 731.1% | -487.1% | 23,565.2% | 8,947.7% |
| Net Income | $577 | -$845 | $5,013 | $2,169 |
| % Margin | 528.6% | -935.5% | 22,585.2% | 8,346.6% |
| EPS Diluted | 0 | -0 | 0 | 0 |
| % Growth | 137% | -133.3% | 0% | – |
| Operating Cash Flow | -$165 | -$285 | -$258 | -$234 |
| Capital Expenditures | $0 | $0 | -$58 | -$4 |
| Free Cash Flow | -$165 | -$285 | -$316 | -$238 |